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1. Introduction 
Calmodulin, a calcium-binding protein of wide 
tissue and species distribution, appears to be impor- 
tant in Ca’+-mediated intracellular processes (review 
[ 1,2]). The Ca2’-calmodulin complex has been 
demonstrated to modulate several enzymatic activities 
including cyclic nucleotide phosphodiesterase, adenyl 
cyclase , phosphorylase kinase , myosin light-chain 
kinase (MLCK) and Ca2+-ATPase. 
The stimulation of insulin secretion in vitro by 
most secretagogues requires extracellular Ca2+ [3,4] 
and is associated with changes in Ca2+ handling by the 
&cell [S ,6 1. The key regulatory component in this 
process may be an increase in the intracellular free 
[Ca”] (review [7]) which would promote Ca”/cal- 
modulin interaction. Insulin secreting tissues have a 
high content of calmoduhn [8,9] and insulin secretion 
is inhibited by calmodulin antagonists [ 1 O-l 21. 
The Ca2’-calmodulin-mediated phosphorylation 
of myosin light-chains (MLC) prepared from non- 
muscle cells leads to aggregation of myosin molecules 
into short bipolar filaments and activation of the 
actomyosin ATPase [ 131. in smooth muscle cells also, 
activation of the actomyosin ATPase accompanies 
phosphorylation [ 141. In skeletal muscle changes in 
MLC phosphorylation are also evident, however, Ca2+ 
sensitivity of the actomyosin ATPase seems to be 
conferred principally by the troponin/tropomyosin 
complex [ 151. Actin and myosin have been detected 
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in islets of Langerhans and contractile processes have 
been implicated in the mechanism whereby insulin 
secretory granules move within the cell and fuse with 
the plasma membrane during exocytosis [16-l 81. 
Such processes may be influenced by a Ca2’-cal- 
modulin-dependent MLCK. 
This paper demonstrates MLCK activity in rat 
pancreatic islets and in a rat transplantable islet cell 
tumour. The partially purified tumour enzyme was 
activated by calmodulin at physiological [Ca”]. The 
tumour used in these studies releases insulin by a 
mechanism indistinguishable from islet tissue [ Ill, 
and calmodulin isolated from the tumour is identical 
to that purified from bovine or rat brain as assessed 
on a broad range of physical and biochemical criteria 
191. 
2. Methods 
2.1. MLCK assays 
The rat islet cell tumour was propagated by sub- 
cutaneous implantation in an inbred strain of rats 
[9,19]. Pancreatic islets were isolated by collagenase 
digestion [20] from untreated animals of the same 
strain. 
MLCK activity was usually determined electropho- 
retically. Samples (2-50 c(g protein) were incubated 
for I-20 mm at 30°C in 50 /.d 50 mM MES (pH 6.9) 
containing 1 mM MgC12, 0.1 mM DTT, 5.1 mM EGTA 
and 60 PM [Y-~~P] ATP (4 X lo6 dpm; prepared as in 
[21] from carrier free 32Pi; Amersham Intl., Bucks.). 
Other additions included 5 /.IM chicken gizzard MLC 
(prepared as in [22]), 1.2 PM bovine brain calmodu- 
lin (prepared as in [9]) and 5 mM CaC12 which resulted 
in free Ca2+ estimated at 15 PM [23]. The reaction 
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was terminated by addition of 30 /.d 200 mM Tris- 
HCl (pH 6.8) containing 20% (w/v) sucrose, 2% (w/v) 
SDS, 10 mM DTT, 0.02% bromophenol blue and 
heating to 1OO’C for 5 min. Samples (50 fl) were 
electrophoresed on polyacrylamide slab gels polymer- 
ised from 17.5% (w/v) acrylamide and O.O73%N,iV’- 
methylene-bisacrylamide using the buffer system in 
[24]. After staining with Kenacid blue R, radioactiv- 
ity incorporated into MLC was determined either by 
autoradiography orby removal of the MLC band and 
determination of its radioactivity by Cerenkov count- 
ing. 
The kinetic constants of the partially purified 
MLCK were determined as in [25,26]. Samples 
(0.3 pg protein) were incubated for 20 min in 100 @l 
of Tris-HCl (pH 7.4) containing 10 mM MgC12, 
0.1 mM DTT, 50 mM KCl, 5 mM EGTA or 0.1 mM 
CaC12, 0.025-0.3 mM [Y_~‘P] ATP (2 X lo6 dpm), 
8-85 E.~M LC and 1.2 I.IM calniodulin. Each reaction 
was terminated by addition of trichloroacetic acid, 
the phosphorylated proteins recovered by filtration 
(type HA 0.45 pm, Millipore Corp.) and the radioac- 
tivity determined by Cerenkov counting. 
2.2. Partial purification of islet cell tumour MLCK 
Fresh tumour was homogenised in 10 mM MES 
(pH 6.9) containing 0.27 M sucrose, 1 mM EGTA and 
1 mM PMSF. The supernatant obtained after centrif- 
ugation at 40 000 X g for 60 mm was passed through 
a 1 X 5 cm column of DEAE-Sephadex equilibrated 
with 0.4 M NH4HC03 (pH 7.9) containing 1 mM 
EGTA, and eluted by 4 bed vol. of this buffer. This 
was done to remove ndogenous calmodulin which 
remained bound to the column. The eluate, which 
contained 90% of the initial protein was adjusted to 
2 mM CaCl, and chromatographed ona 2 X 25 cm 
affinity column prepared by coupling 20 mg bovine 
brain calmodulin to 80 ml Sepharose 4B by the CNBr 
method [27]. 
3. Results and discussion 
3.1. MLCK activity in tissue extracts 
Little incorporation of radioactivity into peptides 
with M,-values equivalent to MLC was observed in 
crude extracts of the islet cell tumour (fig.1 A) in the 
presence of EGTA alone, Ca2+ alone or with Ca2+ 
combined with calmodulin (tracks 1 -I). Added MLC 
were markedly phosphorylated under these conditions 
Fig.1. Autoradiogmm showing phosphorylation of MLC by 
!A) an islet cell tumour and (B) pancreatic islets. Tissues 
(S-10 mg/ml) were disrupted in 50 mM MES (pH 6.9) by 
sonication for 10 s at 4’C (medium setting MSE ultrasonic 
disintegrator Mk2, MSE Crawley, Sussex). Extracts were 
incubated with [r-“P]ATP for 1 mm, the phosphorylated 
proteins separated by polyacrylamide gel electrophoresis and 
the gels stained, dried and autoradiographed. Tracks 2,4,6,8,10 
have 5 mM Ca’+ added in addition to 5.1 mM EGTA. Other 
additions were: (3,4) calmodulin; (5,6) MIX; (7,8) calmodu- 
lin and MLC; (9,lO) calmodulin, MLC and trifluoperazine 
(100 PM). M, standards used were: phosphorylase (98 000); 
bovine serum albumin (68 000); ovalbumin (45 000); car- 
bonic anhydrase (31 000); myoglobin (17 000). 
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(track 5). The activity, then, m me presence of Ca’+ 
was 2-5-fold greater than that with EGTA alone 
(track 6). Addition of calmodulin (track 8) did not 
further enhance the Ca*+-dependent phosphorylation 
of MIX, however, there was presumably sufficient 
endogenous calmodulin in the tumour extract for full 
expression of activity. Consistent with this interpreta- 
tion, the Ca*+-enhanced phosphorylation was abol- 
ished by the calmodulin antagonist trifluoperazine 
(track 10). Homogenates of islets of Iangerhans, ub- 
jected to the same protocol, gave identical results 
(fig.lB). 
It was important o establish whether the MLCK 
activity observed was a property of the insulin-con- 
taining cell or derived from associated tissue. The 
tumour used in these studies is principally composed 
of cells with a typical Pcell morphology. Unlike islets 
it does not appear to possess glucagon-, pancreatic 
polypeptide- or somatostatincontaining cells as deter- 
mined by sensitive immunoassay procedures (Professor 
L. H. Rees, Drs T. E. Adrian and S. R. Bloom, per- 
sonal communication). In the adrenal medulla local- 
isation studies have shown that much of the myosin 
and hence possibly MLCK activity is associated with 
muscle cells of the vascular bed [28]. The Ca*‘-cal- 
modulin-dependent MLCK activity determined in the 
vessel entering the tumour (1.4 f 0.4 nmol . min-’ .
mg-’ (n = 4)) was not significantly greater than that 
of the whole tumour (1.2 + 0.1). The uterus, which 
like the vasculature isa rich source of smooth muscle, 
had an activity of 3.9 * 0.2 nmol . min-’ . mg-’ in the 
present assay. It would seem therefore that the /I-cell 
contains a substantial proportion of the MLCK activ- 
ity observed. 
3.2. Partially putified MLCK activity 
The tumour was used for the partial purification 
of the Ca*+--calmodulin-dependent MLCK activity; a 
summary of the procedure and the resultant yield of 
enzyme activity is shown in table 1. The calmodulin- 
affinity column used in the final step of the purifica- 
tion (flg.2) resolved 2 major forms of MLCK activity. 
The presence of 2 forms has been observed in other 
tissues [30]. The first of these which did not interact 
with the affinity support, did not depend on Ca*+ or 
calmodulin for activity. The second form which was 
Ca*+-calmodulin-dependent was further characterised. 
Phosphorylation of added MLC in the absence of 
Ca’+ occurred at a rate equivalent to 4% of the max- 
imum achieved with added Ca*+ and calmodulin. Ca*+ 
6 
Table 1 
Summary of the purification of islet cell tumour MLCK 
Ca*+-cahnodulin-dependent MLCK 
act. 
Protein Total act. Spec. act. 
(mg) (nmol/min) (nmol . min-’ . mg-‘) 
Initial 
homogenate 768 1175 1.5 
Supernatant: 
40 000 x g 
for 60 min 234 662 2.8 
DEAE- 
Sephadex 197 660 3.4 
Calmodulir- 
Sepharose 4B 3.2 199 62.3 
MLCK activity was determined electrophoretically at each 
stage in the purification as described except ATP and MLC 
were increased to 0.2 mM and 55 PM, respectively. Values 
were corrected for activity observed in the presence of EGTA 
0 100 200 300 400 
VOLUME ELUTED (ml) 
Fig.2. Cahnodulin-affinity chromatography of MLCK. The 
calmodulin-depleted material from the ion-exchange column 
(-20 mg) was applied to a calmodulin-Sepharose 4B column 
equilibrated with 20 mM Hepes (pH 6.9) containing 0.3 M 
NaCl and 1 mM CaCl,. The eluate was recirculated 4 times, 
the column washed with 4 vol. buffer then with the same 
buffer containing 1 mM EGTA. The eluate was stored at 4°C 
with 1 mM PMSF, 0.1 mg/ml lima bean trypsin inhibitor, 
0.1 mM p-tosyl-Larginine methyl ester hydrochloride and 
0.1 mM L-l-tosylamide-2-phenylethylchloromethyl ketone. 
MLCK was assayed electrophoretically. Protein (m----m) was 
measured as in [29]; Ca*+-calmodulindependent MLCK 
(e-o) and Ca’+-calmodulin-independent MLCK (o-o) 
were both expressed as a % of the maximum observed in the 
presence of Ca2+ and calmodulin. 
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Table 2 
The effect of Ca”., cahuodulin and trifluoperazine on 
MLCK activity 
Addition Ca*+ 32P incorp. into MLC 
(area of peak) 
None 
MLC 
MLC + calmodulin 
MLC, calmodulin + 
trifhroperazine 
- <O.l 
+ <O.l 
- 0.1 
+ 9.3 
_ 1.1 
+ 18.1 
- 1.2 
+ 1.2 
MLCK activity was determined electrophoretically and the 
relative radioactivity incorporated into MLC determined by 
densitometry of the autoradiograph 
alone caused 50% of the maximal phosphorylation, 
but as in crude extracts this was abolished by trifluo- 
perazine. It was demonstrated by direct assay as in 
[9] that in spite of the precautions taken there was 
still sufficient calmodulin in the final eluate to account 
for this phenomenon. 
The apparent Km -values for ATP and theMr 20 000 
light-chain of chicken gizzard myosin were 70 E.~M and 
. 
ld8 10' ld 1ll-5 lo4 
Cd* CONCENTRATION (Ml 
Fig.3. The effect of [Ca’+] on MLCK phosphorylation. 
MLCK activity (o-o) was determined electrophoretically 
in the presence of varying [Ca’+]. The % conversion of MLCK 
to the cahnodulin - MLCK complex (o-o) was calculated 
from the intrinsic K, for MLCK . cahnodulin [ 151, the Ka- 
values for Ca binding to calmodulin in the presence of 1 mM 
MgCI, [ 341 and assuming that only cahnodulin bearing 4 Ca 
atoms/m01 interacted with the enzyme. Calmodulin was 
maintained at 1.2 PM. [MLCK] was estimated at 2.5 nM on 
the basis of the specific activity of the purified brain enzyme 
[ 331. The calculated activity was not affected significantly by 
variation of [enzyme] from 0.1 r&l--O.1 PM. 
44 PM, respectively. These values are similar to those 
observed for MLCK isolated from chicken gizzard 
[31], human platelets [32] and bovine brain [33]. 
Under the standard assay conditions the partially 
purified MLCK was half-maximally activated by Ca’+ 
at 1.3 PM. The Ca’+-dependency showed positive 
cooperativity with a Hill coefficient of -2. Such 
findings were concordant with those reported for the 
skeletal muscle nzyme [ 151. The cooperativity may 
be accounted for by the requirement of the binding 
of 3 or 4 Ca atoms to calmodulin before activation 
can occur. Calculation of the concentration of the 
Car . calmodulin . MLCK complex from the reported 
K,-values for Ca binding to calmodulin [34] and the 
intrinsic K, for MLCK - calmodulin [151 with the 
assumption that only Caf+ -calmodulin binds to 
MLCK and activates it, gave a Ca2+ concentration to 
activity relationship consistent with the observed 
findings. Under conditions prevailing in vivo in the 
P-cell where the calmodulin concentration may be 
30-50 PM [8], MLCK would be expected to be half- 
maximally activated at approximately the Ca2+ con- 
centration presently observed on the basis of such 
calculations. 
The Ca’+aensitivity of MLCK activity thus falls 
within the concentration range of cytosolic free Ca2+ 
believed to occur during activation of insulin secretion. 
As such it is compatible with a physiological role for 
this enzyme in the secretory response. 
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